Area of research
Cancer Research · Oncology
Research interest
Research interests include Pancreatic and Hepatic Oncology Research, Cancer Genomics and Diagnostics, Epigenetics and DNA Methylation, and Circular RNAs in diseases.
Tumour-selective activity of RAS-GTP inhibition in pancreatic cancer
Author Correction: Tumour-selective activity of RAS-GTP inhibition in pancreatic cancer
A Transcriptome-Based Precision Oncology Platform for Patient–Therapy Alignment in a Diverse Set of Treatment-Resistant Malignancies
An NFATc1/SMAD3/cJUN Complex Restricted to SMAD4-Deficient Pancreatic Cancer Guides Rational Therapies
Tumor restriction by type I collagen opposes tumor-promoting effects of cancer-associated fibroblasts
GOT1 inhibition promotes pancreatic cancer cell death by ferroptosis
Cysteine depletion induces pancreatic tumor ferroptosis in mice
Tuft Cells Inhibit Pancreatic Tumorigenesis in Mice by Producing Prostaglandin D2
Interleukin-1β-induced pancreatitis promotes pancreatic ductal adenocarcinoma via B lymphocyte–mediated immune suppression
A DNA Hypomethylating Drug Alters the Tumor Microenvironment and Improves the Effectiveness of Immune Checkpoint Inhibitors in a Mouse Model of Pancreatic Cancer
Noninvasive Young's modulus visualization of fibrosis progression and delineation of pancreatic ductal adenocarcinoma (PDAC) tumors using Harmonic Motion Elastography (HME) <i>in vivo</i>
Experimental microdissection enables functional harmonisation of pancreatic cancer subtypes
Cholinergic Signaling via Muscarinic Receptors Directly and Indirectly Suppresses Pancreatic Tumorigenesis and Cancer Stemness
Dclk1 Defines Quiescent Pancreatic Progenitors that Promote Injury-Induced Regeneration and Tumorigenesis
Surface-enhanced resonance Raman scattering nanostars for high-precision cancer imaging
Bmi1 is required for the initiation of pancreatic cancer through an Ink4a-independent mechanism
Stromal Elements Act to Restrain, Rather Than Support, Pancreatic Ductal Adenocarcinoma